This inventor holds 2 USPTO granted patents. Top assignee: Chong Kun Dang Corporation. Active years: 1999-2003.
Company Filing History:
Years Active: 1999-2003
Title: Innovations of Jong Gwan Kim
Introduction
Jong Gwan Kim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of immunosuppressive agents. With a total of 2 patents, his work has implications for both medical and pharmaceutical applications.
Latest Patents
His latest patents include "Streptomyces sp producing tautomycetin" and "immunosuppressant comprising tautomycetin as active ingredient." The first patent relates to a novel microorganism, Streptomyces sp., which produces tautomycetin, known for its immunosuppressive and antibacterial activities. This invention outlines a process for preparing tautomycetin from the microorganism and describes its use in immunosuppressive pharmaceutical compositions. The second patent focuses on the development of a method for large-scale manufacturing of tautomycetin, demonstrating its effectiveness in suppressing interleukin-2 production and graft rejection in organ transplantation.
Career Highlights
Jong Gwan Kim is associated with Chong Kun Dang Corporation, where he continues to innovate in the field of pharmaceuticals. His research has led to advancements in understanding the mechanisms of immunosuppression and antibiotic activity, contributing to the development of new therapeutic options.
Collaborations
He has collaborated with notable colleagues, including Jung Woo Kim and Hyoung Sik Chun, to further enhance the research and development of his inventions.
Conclusion
Jong Gwan Kim's contributions to biotechnology through his patents reflect his commitment to advancing medical science. His work on tautomycetin showcases the potential for innovative solutions in immunosuppressive therapies.